(Reuters) – Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs. The largest U.S. drugmaker agreed to pay a hefty premium ... More »
TOKYO (Reuters) – The Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressure which was found to contain a substance that can cause cancer, the drugmaker said on Friday. More than 763,000 tablets of the drug Amvalo, which were manufacture... More »
(Reuters) – Pfizer Inc said on Monday a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in certain patients, the secondary goal of a late-stage trial. Ibrance is Pfizer’s blockbus... More »
NEW YORK (Reuters) – Mylan N.V.’s (MYL.O) emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment’s manufacturer said on Friday. EpiPens deliver potentially lifesaving doses of the g... More »
(Reuters) – Pfizer Inc’s experimental drug to treat a rare and fatal disease linked to heart failure reduced deaths and need for hospitalizations in a late-stage study. The company’s clinical study investigated the efficacy, safety and tolerability of an oral ... More »
FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo U.S. drugmaker Pfizer Inc said on Wednesday it reached an agreement with Sangamo Therapeutics Inc for rights to its gene therapy program... More »
FILE PHOTO – The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly/File Photo Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investi... More »
U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. More »
FILE PHOTO – The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration said Pfizer Inc’s process for manufacturing sterile injectable drugs at a plant... More »
A man walks past Pfizer’s world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo Pfizer Inc said it received subpoenas from the U.S. Attorney’s Office for the District of Massachusetts related to its support for organizations that provi... More »
A company logo is seen at a Pfizer office in Dublin, Ireland November 24, 2015. REUTERS/Cathal McNaughton Pfizer Inc’s Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and napro... More »
The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly U.S. drugmaker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies at this time. More »
Pfizer Inc (PFE.N) is buying Anacor Pharmaceuticals Inc (ANAC.O) in a $5.2 billion deal to add an eczema gel to its portfolio, a month after the U.S. drug major scrapped plans to buy Allergan Plc (AGN.N). Anacor shares rose 54 percent to $98.60 in premarket tr... More »
NEW YORK – Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest U.S. drugmaker said on Friday. “We are enforcing a distribution restriction for specific products that have been part of, or considered by some... More »
MUMBAI/NEW DELHI Shares in the Indian units of U.S.-based drugmakers Pfizer (PFE.N) (PFIZ.NS) and Abbott Laboratories (ABT.N) (ABOT.NS) fell as much as 5 percent on Monday after authorities imposed a ban on their codeine-based cough syrups, saying they posed a... More »
Pfizer Inc (PFE.N) secured formal board approval on Sunday for its acquisition of Botox maker Allergan Plc (AGN.N) for more than $150 billion, a deal that will create the world’s biggest drug maker, according to people familiar with the matter. The deal, the l... More »
LONDON Pfizer’s stop-smoking drug Chantix does not raise risks of heart attack or depression, contrary to previous reports, and should be recommended to more smokers wanting to quit, scientists said on Monday. In a study tracking 150,000 smokers in England for... More »
